2020-2025 Global Bioactive Peptides Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Bioactive peptides are a form of prepropeptides, which are synthesized in the cell and modified to active proteins. Bioactive Peptides act as signaling molecules in pathogenesis and physiological functions. They are inactive forms and released during food processing or gastrointestinal digestion. Bioactive peptides act as a regulatory compound like hormones after they liberated. The source of bioactive peptides is milk, plant, and meat. Bioactive peptides produced by enzyme proteolysis derived from microorganisms, hydrolysis by digestive enzymes and milk fermentation with proteolytic starter clusters. The most common of production bioactive peptides are enzymatic hydrolysis. Many bioactive active peptides produced using Pepsin or trypsin (produces calcium binding phosphopeptides and Angiotensin-converting enzyme inhibitory peptides). Apart from the natural way of bioactive peptides production, recombinant DNA techniques also used. Bioactive peptides also generated through non-starter and starter bacteria. The also play an important role in the regulation of digestive system and modulation of nutrient absorption. Upon administration, they affect major body systems like digestive, immune, cardiovascular, and nervous system.
This report elaborates the market size, market characteristics, and market growth of the Bioactive Peptides industry, and breaks down according to the type, application, and consumption area of Bioactive Peptides. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Bioactive Peptides in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Bioactive Peptides market covered in Chapter 13:
New England Peptide
Naturade
Phermpep
Arlak Biotech
WN Pharmaceuticals
VentureRadar
Ingredia SA
Seagarden

In Chapter 6, on the basis of types, the Bioactive Peptides market from 2015 to 2025 is primarily split into:
Anti-Hypertensives
Cardiovascular System
Nervous System
Gastrointestinal System
Immune System

In Chapter 7, on the basis of applications, the Bioactive Peptides market from 2015 to 2025 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Drug Store
Mail-Order Pharmacy

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:


Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
Maia-17072720

05-Jan-2021

128
License